: CR associated with fibrosis is a major cause of allograft failure since the advent of immunosuppressive drugs that block acute rejection. The hypothesis to be tested here is that CR is driven by T cells that are stimulated by donor antigen peptides presented by APC of the recipient at a time when surgery related inflammation has waned. It is further proposed that this environment causes donor antigen peptide specific T cells to differentiate into type 2 lymphokine (IL-4, IL-5, IL-6, IL-10) producing cells. These lymphokines are proposed to directly or indirectly cause fibrosis within the graft. This hypothesis will be tested using a novel C57BL/6 (B6) Tg mouse line that expresses ovalbumin (OVA) on all cells of the body. Preliminary results show that skin grafts from OVA B6 donors are acutely rejected by B6 recipients in a T cell dependent fashion. In the first aim, an attempt will be made to identify conditions that convert this process into CR by treating recipients with cyclosporine A to allow OVA B6 skin grafts to survive the period of surgery related inflammation, by forcing antigen presentation by recipient APC by removing MHC molecules from OVA B6 donors, and by grafting OVA B6 tracheas that undergo CR naturally. In the second aim, the conditions that result in CR will be used to determine which T lymphocyte subset is responsible and whether or not these cells produce type 2 lymphokines. This approach will be strengthened by the use of adoptive transfer of OVA reactive TCR transgenic CD4 and CD8 T cells to physically track the location and function of specific T cells during CR. The experiments proposed in the third aim will rely on IL-4 deficient recipients and IL-12 administration to test a causal relationship between type 2 lymphokine production by graft antigen specific T cells and the subsequent fibrosis that impairs graft function. It is hoped that an improved understanding of the immunological processes that underlie CR will lead to therapies aimed at graft antigen specific tolerance or treatment of fibrosis.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Program Projects (P01)
Project #
5P01AI050162-02
Application #
6651248
Study Section
Special Emphasis Panel (ZAI1)
Project Start
2002-09-01
Project End
2003-06-30
Budget Start
Budget End
Support Year
2
Fiscal Year
2002
Total Cost
Indirect Cost
Name
University of Minnesota Twin Cities
Department
Type
DUNS #
168559177
City
Minneapolis
State
MN
Country
United States
Zip Code
55455
Patil, Jagadish; Lande, Jeffrey D; Li, Na et al. (2008) Bronchoalveolar lavage cell gene expression in acute lung rejection: development of a diagnostic classifier. Transplantation 85:224-31
Lande, Jeffrey D; Patil, Jagadish; Li, Na et al. (2007) Novel insights into lung transplant rejection by microarray analysis. Proc Am Thorac Soc 4:44-51
Richards, D M; Zhang, N; Dalheimer, S L et al. (2007) Allopeptide-specific CD4(+) T cells facilitate the differentiation of directly alloreactive graft-infiltrating CD8(+) T Cells. Am J Transplant 7:2269-78
Jacobson, Blake A; Alter, Michael D; Kratzke, Marian G et al. (2006) Repression of cap-dependent translation attenuates the transformed phenotype in non-small cell lung cancer both in vitro and in vivo. Cancer Res 66:4256-62
Larsson, Ola; Perlman, David M; Fan, Danhua et al. (2006) Apoptosis resistance downstream of eIF4E: posttranscriptional activation of an anti-apoptotic transcript carrying a consensus hairpin structure. Nucleic Acids Res 34:4375-86
Huddleston, S J; Hays, W S; Filatenkov, A et al. (2006) CD154+ graft antigen-specific CD4+ T cells are sufficient for chronic rejection of minor antigen incompatible heart grafts. Am J Transplant 6:1312-9
Vanasek, Tracy L; Nandiwada, Sarada L; Jenkins, Marc K et al. (2006) CD25+Foxp3+ regulatory T cells facilitate CD4+ T cell clonal anergy induction during the recovery from lymphopenia. J Immunol 176:5880-9
Dalheimer, Stacy L; Richards, David M; Mueller, Daniel L (2005) Sharing of class I MHC molecules between donor and host promotes the infiltration of allografts by mHAg-reactive CD8 T cells. Am J Transplant 5:832-8
Avdulov, Svetlana; Li, Shunan; Michalek, Van et al. (2004) Activation of translation complex eIF4F is essential for the genesis and maintenance of the malignant phenotype in human mammary epithelial cells. Cancer Cell 5:553-63
Richards, David M; Dalheimer, Stacy L; Ehst, Benjamin D et al. (2004) Indirect minor histocompatibility antigen presentation by allograft recipient cells in the draining lymph node leads to the activation and clonal expansion of CD4+ T cells that cause obliterative airways disease. J Immunol 172:3469-79

Showing the most recent 10 out of 13 publications